Download presentation
Presentation is loading. Please wait.
Published bySusan Elliott Modified over 9 years ago
1
FBW7/CDC4 and Endometrial Cancer Michael Mastropole
2
Overview FBW7/CDC4 is a family of genes Tumor suppressor Directly binds to cyclin E Mutated in about 16% of endometrial cancers
3
Ubiquitylation http://upload.wikimedia.org/wikipedia/commons/7/7f/Ubiquitylation.png
4
The SCF Complex (E3 ligase) Wang et al. 2012
5
CDC4 targets Cyclin E for Proteolysis Strohmaier et al. 2001
6
http://eweb.furman.edu/~wworthen/bio111/4cyclins.jpg Cyclin E is required for G1/S Transition
7
Mouse Model Wang et al. 2012
8
Endometrial Cancer Endometrium- lining of the uterus Typically occurs within a few decades of menopause 49,560 new cases in 2013
9
hCDC4 mutations Spruck et al. 2002
10
Treatments Surgery – Hysterectomy along with removal of ovaries, fallopian tubes, and lymph nodes – Helps stage the cancer Chemotherapy – Taxol Radiation Potential Treatments – Cdk2 inhibitors www.cancer.org
11
Prognosis 1 year survival rate – 92% 5 year survival rate if cancer has not spread – 95% 5 year survival rate if cancer has spread – 23% www.nlm.nih.gov
12
References http://www.nature.com/nature/journal/v413/n6 853/full/413316a0.html http://cancerres.aacrjournals.org/content/62/16/ 4535.long http://www.cancer.org/cancer/endometrialcance r/detailedguide/endometrial-uterine-cancer- treating-by-stage http://www.nlm.nih.gov/medlineplus/ency/articl e/000910.htm http://www.sciencedirect.com/science/article/pii /S0014579312002049
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.